$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000101008616000026 Filed on August 08, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q2
Revenue	$4.700M	$1.900M	$1.500M
YoY Change	261.54%	26.67%	114.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.855M	$3.739M	$2.605M
YoY Change	23.01%	43.53%	-5.2%
% of Gross Profit
Research & Development	$6.069M	$2.948M	$2.959M
YoY Change	150.06%	-0.37%	24.75%
% of Gross Profit
Depreciation & Amortization	$42.66K	$43.59K	$68.08K
YoY Change	-18.42%	-35.97%	-24.1%
% of Gross Profit
Operating Expenses	$12.72M	$11.19M	$5.800M
YoY Change	156.68%	92.86%	7.47%
Operating Profit	-$8.062M	-$9.285M	-$4.332M
YoY Change	122.15%	114.34%	-8.74%
Interest Expense	$94.78K	$10.21K	$13.32K
YoY Change		-23.29%	-89.23%
% of Operating Profit
Other Income/Expense, Net	$30.76K	$58.49K	$10.88K
YoY Change	146.38%	437.73%	934.92%
Pretax Income	$9.200M	$9.600M	$6.500M
YoY Change	64.29%	47.69%	-237.62%
Income Tax	-$4.072K	$1.470K	$88.35K
% Of Pretax Income	-0.04%	0.02%	1.36%
Net Earnings	-$9.244M	-$9.566M	-$6.573M
YoY Change	64.16%	45.53%	122.96%
Net Earnings / Revenue	-196.68%	-503.47%	-438.2%
Basic Earnings Per Share
Diluted Earnings Per Share	-$169.4K	-$177.1K	-$123.1K
COMMON SHARES
Basic Shares Outstanding	53.87M shares	54.16M shares	53.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.50M	$78.00M	$115.7M
YoY Change	-84.15%	-32.58%	16.87%
Cash & Equivalents	$20.49M	$78.02M	$115.7M
Short-Term Investments
Other Short-Term Assets	$9.600M	$2.100M	$8.000M
YoY Change	17.07%	-73.75%	-39.39%
Inventory	$17.75M	$28.93M	$8.770M
Prepaid Expenses
Receivables	$38.75M	$34.49M	$769.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$86.58M	$143.6M	$133.2M
YoY Change	-37.94%	7.81%	2.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$330.1K	$372.8K	$446.6K
YoY Change	-27.84%	-16.53%	-55.37%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$642.1K	$641.6K	$1.990M
YoY Change	-67.73%	-67.75%	-0.5%
Total Long-Term Assets	$76.26M	$58.10M	$49.29M
YoY Change	32.27%	17.87%	-38.18%
TOTAL ASSETS
Total Short-Term Assets	$86.58M	$143.6M	$133.2M
Total Long-Term Assets	$76.26M	$58.10M	$49.29M
Total Assets	$162.8M	$201.7M	$182.5M
YoY Change	-17.41%	10.53%	-12.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.925M	$9.917M	$4.781M
YoY Change	-7.85%	107.44%	193.61%
Accrued Expenses	$4.793M	$3.311M	$3.243M
YoY Change	56.47%	2.09%	-32.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$108.3M	$216.9M	$8.024M
YoY Change	1636.51%	2603.02%	-4.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$367.4M	$288.6M	$426.8M
YoY Change	-18.01%	-32.38%	126.42%
Total Long-Term Liabilities	$367.4M	$288.6M	$426.8M
YoY Change	-18.01%	-32.38%	42678.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$108.3M	$216.9M	$8.024M
Total Long-Term Liabilities	$367.4M	$288.6M	$426.8M
Total Liabilities	$476.0M	$505.7M	$441.9M
YoY Change	3.07%	14.46%	123.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$490.7M	-$481.5M	-$435.7M
YoY Change	11.18%	10.5%	167.54%
Common Stock	$177.5M	$177.4M	$176.3M
YoY Change	0.48%	0.6%	1.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$313.2M	-$304.1M	-$259.4M
YoY Change
Total Liabilities & Shareholders Equity	$162.8M	$201.7M	$182.5M
YoY Change	-17.41%	10.53%	-12.89%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$9.244M	-$9.566M	-$6.573M
YoY Change	64.16%	45.53%	122.96%
Depreciation, Depletion And Amortization	$42.66K	$43.59K	$68.08K
YoY Change	-18.42%	-35.97%	-24.1%
Cash From Operating Activities	-$56.23M	-$26.04M	$20.10M
YoY Change	-510.44%	-229.55%	-349.07%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.290M	0.000	10.00K
YoY Change		-100.0%	-102.04%
NET CHANGE
Cash From Operating Activities	-56.23M	-26.04M	20.10M
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	-1.290M	0.000	10.00K
Net Change In Cash	-57.52M	-26.04M	20.11M
YoY Change	-521.7%	-229.49%	-350.12%
FREE CASH FLOW
Cash From Operating Activities	-$56.23M	-$26.04M	$20.10M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$56.23M	-$26.04M	$20.10M
YoY Change	-508.65%	-229.55%	-349.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53874294	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Trading Symbol TradingSymbol	SIGAQ
CY2016Q2	siga	Amount To Be Paid On Effective Dateof Plan Of Reorganization AmountToBePaidOnEffectiveDateofPlanOfReorganization	5000000	USD
CY2011Q2	siga	Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry	50000000	USD
CY2016Q3	siga	Bankruptcy Claims Number Of Claims Outstanding BankruptcyClaimsNumberOfClaimsOutstanding	19000
CY2014Q3	siga	Collateral Collateral	0.50
CY2015Q4	siga	Computer Equipment ComputerEquipment	754502	USD
CY2016Q2	siga	Computer Equipment ComputerEquipment	762977	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2011Q2	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2016Q2	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	0	USD
CY2016Q2	siga	Final Order And Judgment FinalOrderAndJudgment	204000000	USD
CY2015Q1	siga	Finalorderandjudgmentplusinterest Finalorderandjudgmentplusinterest	195000000	USD
CY2011Q2	siga	Holdbackamountpending Fd Aapproval HoldbackamountpendingFDAapproval	102500000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	122700000	USD
CY2016Q2	siga	Covenantsonpharm Atheneliability CovenantsonpharmAtheneliability	50000000	USD
CY2015Q2	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	11365	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	0	USD
	siga	Increasedecreasein Pharm Atheneliability IncreasedecreaseinPharmAtheneliability	203654855	USD
CY2015Q4	siga	Liabilitiessubjecttocompromiseaccountspayable Liabilitiessubjecttocompromiseaccountspayable	834219	USD
CY2016Q2	siga	Pharm Atheneliabilityincludesreimbursableattorneyandexpertfee PharmAtheneliabilityincludesreimbursableattorneyandexpertfee	3200000	USD
CY2015Q2	siga	Pharm Atheneliabilityinterest PharmAtheneliabilityinterest	-13441	USD
CY2016Q2	siga	Liabilitiessubjecttocompromiseaccountspayable Liabilitiessubjecttocompromiseaccountspayable	0	USD
CY2015Q4	siga	Liabilitiessubjecttocompromiselosscontingencylegalfees Liabilitiessubjecttocompromiselosscontingencylegalfees	3226055	USD
CY2015Q4	siga	Liabilitiessubjecttocompromiseotheraccruedexpense Liabilitiessubjecttocompromiseotheraccruedexpense	737883	USD
CY2016Q2	siga	Liabilitiessubjecttocompromiseotheraccruedexpense Liabilitiessubjecttocompromiseotheraccruedexpense	0	USD
CY2016Q2	siga	Net Capital Deficiency NetCapitalDeficiency	304000000	USD
	siga	Number Of Active Contracts NumberOfActiveContracts	1	contract
	siga	Number Of Active Grants NumberOfActiveGrants	1	grant
	siga	Numberofcoursesdeliveredtothegovernment Numberofcoursesdeliveredtothegovernment	126000	USD
CY2016Q2	siga	Numberofcoursesof Tpox Xtobedeliveredtothegovernment NumberofcoursesofTPOXXtobedeliveredtothegovernment	269000	USD
CY2016Q2	siga	Numberofcoursestobedeliveredtothegovernmentincludingfreecourses Numberofcoursestobedeliveredtothegovernmentincludingfreecourses	845000	USD
CY2015Q2	siga	Patent Preparation Fees PatentPreparationFees	235334	USD
	siga	Patent Preparation Fees PatentPreparationFees	568438	USD
CY2016Q2	siga	Patent Preparation Fees PatentPreparationFees	239690	USD
	siga	Patent Preparation Fees PatentPreparationFees	459405	USD
CY2016Q2	siga	Payment To Extend Days To Satisfy Claim PaymentToExtendDaysToSatisfyClaim	100000000	USD
CY2016Q2	siga	Payment To Post Collateral For Surety Bond PaymentToPostCollateralForSuretyBond	1300000	USD
CY2016Q2	siga	Paymenttoextend120daystosatisfypharm Atheneclaim Paymenttoextend120daystosatisfypharmAtheneclaim	20000000	USD
	siga	Pharm Atheneliabilityinterest PharmAtheneliabilityinterest	-26735	USD
CY2016Q2	siga	Pharm Atheneliabilityinterest PharmAtheneliabilityinterest	-4259451	USD
	siga	Pharm Atheneliabilityinterest PharmAtheneliabilityinterest	-7176637	USD
CY2016Q2	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	6300000	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	12200	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	0	USD
CY2011Q2	siga	Reducedholdbackamount Reducedholdbackamount	41000000	USD
CY2016Q2	siga	Reorganization Payments ReorganizationPayments	800000	USD
	siga	Reorganization Payments ReorganizationPayments	2300000	USD
CY2015Q2	siga	Reorganization Professional Fees ReorganizationProfessionalFees	505243	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1069739	USD
CY2016Q2	siga	Reorganization Professional Fees ReorganizationProfessionalFees	34293	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	1732521	USD
CY2015Q2	siga	Reorganization Trusteefees ReorganizationTrusteefees	13000	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	26000	USD
CY2016Q2	siga	Reorganization Trusteefees ReorganizationTrusteefees	20000	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	33000	USD
CY2015Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1467460	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	2659551	USD
CY2016Q2	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1901314	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	3171047	USD
CY2016Q2	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	1200000	USD
	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	2100000	USD
CY2015Q2	siga	Restricted Stock Units RestrictedStockUnits	313337	shares
	siga	Restricted Stock Units RestrictedStockUnits	240000	shares
CY2015Q4	siga	Suretybond Suretybond	2700000	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	842922	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	43634	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3944476	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9916911	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3676730	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34488734	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	580801	USD
CY2016Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	466630	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3388608	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3310723	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	597721	USD
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1660121	USD
CY2015Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	227863	USD
CY2016Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	267319	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3299417	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3387461	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177008371	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177376807	USD
CY2015Q4	us-gaap	Assets Assets	185732936	USD
CY2016Q2	us-gaap	Assets Assets	201668556	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	129458829	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	143567275	USD
CY2016Q3	us-gaap	Bankruptcy Claims Amount Paid To Settle Claims BankruptcyClaimsAmountPaidToSettleClaims	785000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99713929	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115656150	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112711028	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78022356	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15942221	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-34688672	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54114296	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53843044	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54114296	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53843044	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	5411	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	5411	USD
CY2016Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1628603	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	2830395	USD
CY2016Q2	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	273436	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	1951381	USD
CY2015Q2	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	3135	USD
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	5672	USD
CY2016Q2	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	0	USD
CY2015Q4	us-gaap	Deferred Costs DeferredCosts	52936428	USD
CY2016Q2	us-gaap	Deferred Costs DeferredCosts	56188604	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9627	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11445	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	255258371	USD
CY2016Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	288293407	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	265643	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	277088	USD
CY2015Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68076	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	146854	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43592	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88044	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	452696	USD
CY2016Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	455220	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-238501	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2016Q2	us-gaap	Goodwill Goodwill	898334	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	9600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	20000000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6485089	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13554577	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9564381	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20001654	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88348	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172179	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1470	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12764	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2553407	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5894550	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	277582	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30812004	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	13098787	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	3252176	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	233658167	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	33035036	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10273989	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16484805	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1347956	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-33764	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-42114	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	299881	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1500309	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	13315	USD
	us-gaap	Interest Expense InterestExpense	266726	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	10214	USD
	us-gaap	Interest Expense InterestExpense	10214	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	USD
CY2016Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6268570	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	12447088	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	28931893	USD
CY2015Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	12447088	USD
CY2016Q2	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	22663323	USD
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542044	USD
CY2016Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2542043	USD
CY2015Q4	us-gaap	Liabilities Liabilities	470161486	USD
CY2016Q2	us-gaap	Liabilities Liabilities	505743088	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185732936	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	201668556	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7333084	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	216882489	USD
CY2015Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	206972170	USD
CY2016Q2	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-206396829	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	-206972170	USD
CY2015Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	205400068	USD
CY2016Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2015Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0	USD
CY2016Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	203654855	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1987800	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10998	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13930021	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34677674	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-6573437	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13726756	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-9565851	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20014418	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10877	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16341	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	58489	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69800	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	5800130	USD
	us-gaap	Operating Expenses OperatingExpenses	12031937	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	11186241	USD
	us-gaap	Operating Expenses OperatingExpenses	19515385	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4332670	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9372386	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9284927	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16344338	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	749858	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	873019	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1989520	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	641564	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	332218	USD
CY2016Q2	us-gaap	Other Liabilities OtherLiabilities	290104	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	10052	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10998	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	623983	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2124292	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3749242	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3760240	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449825	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	372779	USD
CY2015Q2	us-gaap	Reorganization Items ReorganizationItems	2149981	USD
	us-gaap	Reorganization Items ReorganizationItems	3931806	USD
CY2016Q2	us-gaap	Reorganization Items ReorganizationItems	327729	USD
	us-gaap	Reorganization Items ReorganizationItems	3716902	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2959070	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5766492	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2948391	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5484403	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-461442332	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-481456750	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2592285	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5670272	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3738709	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6394940	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	873023	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	368436	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-284428550	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	-304074532	USD
CY2015Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	389443	USD
CY2016Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	0	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53589268	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53547017	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54216604	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54165450	shares

Files In Submission

Name	View Source	Status
0001010086-16-000026-index-headers.html	Edgar Link	pending
0001010086-16-000026-index.html	Edgar Link	pending
0001010086-16-000026.txt	Edgar Link	pending
0001010086-16-000026-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20160630.xml	Edgar Link	completed
siga-20160630.xsd	Edgar Link	pending
siga-20160630x10q.htm	Edgar Link	pending
siga-20160630_cal.xml	Edgar Link	unprocessable
siga-20160630_def.xml	Edgar Link	unprocessable
siga-20160630_lab.xml	Edgar Link	unprocessable
siga-20160630_pre.xml	Edgar Link	unprocessable
siga-exhibit3112016q2.htm	Edgar Link	pending
siga-exhibit3122016q2.htm	Edgar Link	pending
siga-exhibit3212016q2.htm	Edgar Link	pending
sigaexhibit3222016q2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2016 Q3 Form 10-Q Financial Statement

#000101008616000026 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2016 Q3 Form 10-Q Financial Statement

#000101008616000026 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga